Inventor
Shaw-Fen Sylvia Hu
Inventor
Thousand Oaks, CA, US
Overview
Patents· 27 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides30%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
A61KPreparations for medical, dental or toiletry purposes26%
C12NMicroorganisms or enzymes9%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
A01KAnimal husbandry1%
C12YEnzymes1%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests1%
PatentTitleYear
10,889,648Anti-PD-L1 antibodies and uses thereof202110,570,205Human antigen binding proteins that bind b-Klotho, FGF receptors and complexes thereof202010,526,411Methods and compositions relating to anti-CCR7 antigen binding proteins20209,862,771'Human CGRP receptor binding proteins'20189,574,002'Human antigen binding proteins that bind to a complex comprising β-Klotho and an FGF receptor'20179,517,264'Human FGF receptor and β-Klotho binding proteins'20169,493,577'Human antigen binding proteins that bind β-klotho, FGF receptors and complexes thereof'20169,284,378'Human antigen binding proteins that bind β-Klotho, FGF receptors and complexes thereof'20169,102,731'Human CGRP receptor binding proteins'20158,907,071'Toxin peptide therapeutic agents'20148,470,556'Nucleic acids that encode antigen binding proteins that bind PAR-2'20138,357,367'Antibodies that bind PAR-2'20138,287,872'Methods for treating inflammatory conditions using antibodies that bind PAR-2'20128,236,305'Antibodies that bind PAR-2'20128,158,759'Compositions and methods relating to glucagon receptor antibodies'20128,043,829'DNA encoding chimeric toxin peptide fusion proteins and vectors and mammalian cells for recombinant expression'20117,947,809'Compositions and methods relating to glucagon receptor antibodies'20117,910,102'Methods of using conjugated toxin peptide therapeutic agents'20117,888,482'Antibodies that bind PAR-2'20117,834,164'DNA encoding OSK1 toxin peptide analogs and vectors and cells for combinant expression'20107,833,979'Toxin peptide therapeutic agents'20107,820,623'Conjugated toxin peptide therapeutic agents'20107,611,865'Polynucleotides encoding truncated glial cell line-derived neurotrophic factor'20097,390,781'Methods of using truncated glial cell line-derived neurotrophic factor'20086,210,924'Overexpressing cyclin D 1 in a eukaryotic cell line'20016,184,200'Truncated glial cell line-derived neurotrophic factor'20015,162,215'Method of gene transfer into chickens and other avian species'1992Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1992–2020Patents assigned to AMGEN INC (24)· patent assignee history
1992Based in Newbury Park, CA, US· patent location history
2001–2020Based in Thousand Oaks, CA, US· patent location history
2012–2017Patents assigned to HU SHAW-FEN SYLVIA (9)· patent assignee history
2016–2017Patents assigned to FOLTZ IAN (3)· patent assignee history
2016–2017Patents assigned to KING CHADWICK TERENCE (3)· patent assignee history
2016–2017Patents assigned to LI YANG (3)· patent assignee history
2021Based in Shanghai, CN· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| AMGEN INC | 24 | 1992–2020 |
| HU SHAW-FEN SYLVIAself | 9 | 2012–2017 |
| FOLTZ IAN | 3 | 2016–2017 |
| KING CHADWICK TERENCE | 3 | 2016–2017 |
| LI YANG | 3 | 2016–2017 |
Locations
| Location | Patents | Span |
|---|---|---|
| Thousand Oaks, California, US | 25 | 2001–2020 |
| Shanghai, CN | 1 | 2021 |
| Newbury Park, California, US | 1 | 1992 |